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MALDI mass spectrometry in combination with post-source decay (PSD) analysis is a fast and
easy to apply method for peptide sequencing. In this study, the PSD technique was used to
investigate the inﬂuence of the adaption of one, two, and three caesium cations to angiotensin II
in the gas phase. The PSD spectra of caesium-aggregated angiotensin II show far less
fragmentation in comparison to the protonated one. In the case of singly (doubly) Cs+ substituted
angiotensin II, the PSD mass spectrum shows only fragments with one (two) Cs cation(s). These
results are interpreted in terms of additional interactions of the caesium cation(s) with the peptide.
In order to investigate this suggestion, the molecular structures were calculated with semi-empirical
molecular dynamic (MD) simulations and further optimized at the quantum chemical level (BP86,
SVP) of theory. On the one hand, secondary structures of Cs+ substituted angiotensin II are more
compact than the structure of protonated angiotensin II, indicating electrostatic interactions of the
Cs cations and the heterocyclic structures. Moreover, oxyphilic interactions of the cations with the
oxygen atoms of the peptide backbone also contribute as further van-der-Waals interactions of
the Cs+ substituted angiotensin II. These interactions are able to explain its higher stability due to
reduced dissociation in comparison to the protonated angiotensin II. On the other hand, most MD
simulations of doubly and triply Cs+ substituted angiotensin II show a formation of a [2 Cs] cluster,
surrounded by the peptide molecule. The formation of this cluster would explain the lack of singly
Cs+ substituted fragments in the PSD mass spectrum of doubly Cs+ substituted angiotensin II.
1 Introduction
Since the invention of matrix-assisted laser desorption/ionization
(MALDI) in the 1980s byM. Karas, F. Hillenkamp in Germany
and by K. Tanaka and co-workers in Japan, large fragile
molecules can be transferred into the gas phase.1–5 In combi-
nation with mass spectrometry (MS), MALDI-MS became one
of the most important mass analysis techniques in biochemistry,
physiology and polymer science. Due to the high mass of typical
bio-macromolecular analyte molecules, a reﬂectron type of a
time of ﬂight (TOF) analyzer is built into most commercial
MALDI-TOF devices. After desorption a small fraction of the
(mostly singly) charged analyte molecules decays on their way to
the detector. Mass spectrometric analysis of these generated
fragments frommetastable decay can provide information about
the molecular structure of the analyte molecule (in the case of
peptides: the amino-acid sequence).6–8 This technique is known
under the name of post-source decay (PSD) analysis.
By using the fragment scheme introduced by Roepstorﬀ and
Fohlmann in combination with the detected m/z values of the
fragments, the primary structure of a small peptide (up to a
molecular mass of about 3000 Da) can be easily obtained.9 In
modern MALDI-MS devices, developments like the tandem
mass spectrometer (MALDI-TOF-TOF) are able to produce
PSD-MALDI mass spectra of high quality within seconds of
experimental eﬀort.10 By using this technique, the decay of a
deﬁned analyte (A) ion (e.g. [A+H]+) could be examined
exclusively. The cleavage of the –CO–NH–bond in the peptide
backbone yields y- and b-ions that can be detected with high
signal intensity during PSD-MALDI mass analysis. In general,
MALDImass spectra contain [A+Na]+ or [A+K]+mass peaks
as well as the protonated one [A+H]+ due to contamination
of the MALDI sample.11–13 If the analyte is substituted with a
doubly charged cation or more than one singly charged cation,
the analyte becomes deprotonated, until it is singly positively
charged.
A key factor for the activity of biologically relevant molecules
is their secondary structure. Additional cations could change
the secondary structure of peptides, as we will show in this
paper. The ratio of cation substitution of the analyte A
(i.e. [A+Na]+/[A+H]+) in MALDI mass spectra strongly
increases with the absorbed laser pulse energy, as shown in
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former studies for angiotensin II with potassium.14 Additionally
MALDI experiments with high laser pulse energies suggest a
higher stability of angiotensin II, if alkali metal ion(s) is (are)
attached.15 Nevertheless, the bonding position and resulting
changes of the molecular structure of peptides by substitution
with metal cations are not completely analyzed in the gas phase.
For the present examination, the analyte is angiotensin II
(H2N-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-COOH;m=1046.2 Da).
On the one hand, angiotensin II (Ang) is regarded as a model
system due to the easy detection using MALDI mass spectro-
metry. On the other hand, the peptide plays a vital role in
several cardiological processes like regulation of the blood
pressure and salt homeostasis in human metabolism.16,17 The
investigation of the Cs+-substituted form of the hormone
angiotensin II could be relevant in a medical context, as some
studies suggest.18 Therefore, gas-phase examinations could be
a step to understand the inﬂuence of cation interaction with
various biomolecules, also in solution phase.
According to experiments by Sullards and Reiter, the
additional proton can be located at the side chains of the
amino acids––arginine, histidine, or the carbonyl oxygen
atoms of the peptide backbone.19 Due to the basicity of the
arginine residue, a protonation of this residue seems highly
favourable. These positions could also be preferred by small
cations such as lithium or sodium. The bonding of alkali metal
cations to peptides and other biologically relevant molecules has
been studied extensively, but it is still discussed as recent reports
suggest.20–22 However, many of these are either theoretical
or experimental. Our combined study deals with the direct
inﬂuence of caesium cations on the structure of angiotensin II.
In this work, the change of the secondary structure of protonated
and Cs+-substituted angiotensin II has been examined by
using PSD-MALDI mass spectrometry for the detection of
the fragments of [Ang+H]+, [Ang+Cs]+, [Ang+2Cs-H]+,
and [Ang+3Cs-2H]+. The results are interpreted with regard
to their molecular structures. For that purpose, molecular
dynamics (MD) simulations on the semi-empirical level of
theory have been performed. In comparison to commonly used
classical MD simulations (using force ﬁelds), quantum chemical
approaches are able to describe the changes in the electronic
structure such as bond cleavage or formation. For higher
accuracy of the results of the MD simulations, their geometries
have been further optimized by density functional theory (DFT).
2 Experimental
2.1 Experimental setup
All PSD-MALDI mass spectra have been generated with a
commercial MALDI mass spectrometer (Ultraﬂex II, Bruker
Daltonics, Bremen, Germany). The MALDI samples have been
irradiated with a frequency-tripled Nd-YAG laser (l=355 nm,
t = 5 ns). For obtaining high-quality PSD mass spectra, the
LIFT method has been employed.10 The analyte ions, produced
duringMALDI are accelerated into a linear TOF. After the ﬁrst
TOF, ions of a deﬁned m/z-value were analyzed in a second
reﬂectron-type TOF. This tandem mass spectrometry technique
allows the measurement of a complete PSD mass spectrum in
one step. For further data processing, the program package
FlexAnalysis 2.4 (Bruker Daltonics) has been applied. A
mixture containing a-cyano-4-hydroxycinnamic acid (CHCA)
and sinapic acid (SA) (about 10 mg ml1 each in 3 : 2
acetonitrile/water) was used as a matrix for the MALDI
experiments. Caesium chloride and angiotensin II were prepared
in dest. H2O (about 50 mgml
1 each). This combination generated
a high degree of cationization and also strong fragmentation of
the peptide under MALDI conditions. Samples were spotted on
the MALDI target plates using the dried droplet method.
2.2 Theoretical approach
The exploration of potential energy surfaces of protonated and
cation-substituted angiotensin II has been performed using the
simulated annealing procedure combined with molecular
dynamics simulations at the semi-empirical AM1 level of theory.23
For electronic structure calculations, the MOPAC program
package has been used and MD simulations have been per-
formed with an in-house suite of programs.24 The simulations
were started typically at T = 1000 K and the system has been
exponentially cooled down to T = 0 K within 10 ps of
simulation time. For all structures, several simulated annealing
runs have been carried out by varying the simulation para-
meters such as initial structure and cooling time. The structures
obtained from the simulated annealing procedure have been
further optimized using DFT (with RI approximation). For
this purpose the gradient corrected BP86 functional together
with single split valence plus polarization (SVP) basis sets have
been employed together with the relativistic eﬀective core
potential (ECP) for the Cs atom.25–30 All DFT calculations
have been performed using the ORCA (version 2.7) package.31
3 Results and discussion
This section is separated into four parts. The ﬁrst part
describes the PSD mass spectrum and the molecular structure
of protonated angiotensin II ([Ang+H]+). The three other parts
report on the singly ([Ang+Cs]+), doubly ([Ang+2Cs-H]+),
and triply ([Ang+3Cs-2H]+) Cs+-substituted angiotensin II.
For convenience of expression we chose to denote the
replacement of a single proton by a Cs+ ion ‘‘caesiation’’ (in
analogy with deuteration) and the substituted peptide ‘‘caesiated’’.
3.1 Protonated angiotensin II
PSD mass spectra of protonated angiotensin II are well
known.32,33 Main fragments are y- and b-ions. Our PSD mass
spectrum shows slightly higher signals for fragments near the
termini (see Fig. 1).
The result of a DFT optimized calculation is shown in Fig. 1
for the uncharged (left) and protonated (right) molecular
structure. As a reference conﬁguration for all calculations of
angiotensin II, a structure from the Protein Data Base (1N9V)
has been used. The backbone of the uncharged molecule
appears in a rather linear form (sort of a stretched helix),
besides the bend resulting from valine.
The calculated molecular structure of [Ang+H]+ shows a
mainly linear structure of the backbone as well as the uncharged
molecule. Only minor modiﬁcations due to electrostatic inter-
action of the additional proton can be observed. The results
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additional proton on the secondary structure and the stability
of the molecule in the gas phase. Therefore, we present the
structure where the additional proton is located at the arginine
residue. Experimentally, this result is in agreement with the
rather high gas-phase fragmentation abundance, as shown in
the corresponding PSD mass spectrum.
3.2 Singly caesiated angiotensin II
The PSD mass spectrum of singly caesiated angiotensin II
([Ang+Cs]+) (Fig. 2) shows distinctly less fragmentation than
the protonated peptide. For better visibility, the range of m/z
of 200 to 1000 has been enlarged. Shifted fragments (mostly
y-fragments and some a- and b-fragments) were obtained with
a low ion signal. Mass peaks with a m/z value lower than 400
(e.g. [y1+Cs]
+ or [y2+Cs]
+), are below the noise level. The
lower level of fragmentation indicates a higher stability of the
oligopeptide protecting it from metastable decay in the reﬂectron-
TOFmeasurement. Uncaesiated fragments could not be identiﬁed.
The calculated secondary structure of Cs+-substituted
angiotensin II shows a strong change of the secondary structure
because of interaction between the (hetero-) cyclic side chains
and the (centered) Cs cation. Some simulations also show an
interaction of the oxygen atoms of the peptide backbone with
the cation and could be described as van-der-Waals interactions
of the polarized oxygen atoms and the Cs cation. However,
these interactions seem to be weaker than the interaction of the
cations and the heterocyclic residues (e.g. tyrosine or histidine).
The interactions change the structure such that the peptide
forms a cage-like structure around the cation, as shown in
Fig. 2. The main reason for this seems to be the interaction of
the cation and the arginine/aspargine, the aromatic ring of the
tyrosine and phenylalanine and the heterocyclic rest of the
histidine. The delocalized p-systems of (ring) structures build
up an attractive interaction with charged particles, here
Cs+cations.34 This attractive interaction seems to be the main
stabilizing factor of the molecular structure preventing it from
fragmentation during mass spectrometry. The lack of several
fragments, and the increased intensity of some y- and b-fragment
ion signals with higher fragment size indicate a stable position of
the substituted cation and its interaction with the peptide. In
particular, the high ion signal of the y7-fragment could be the
result of the higher basicity of the fragment in comparison to
Fig. 1 In the upper part of the ﬁgure, the PSD MALDI mass
spectrum of protonated angiotensin II is shown. The peak intensities
of the fragments are in the same range as the [Ang+H]+ mass peak.
The numbers refer to the m/z value of the fragments. The ion intensity
of fragments in the middle mass range is slightly lower. In the lower
part of the ﬁgure, the unprotonated (left) and the protonated (right)
angiotensin II structures are shown. The additional proton in the right
structure is located at the arginine residue. The green ribbon indicates
the backbone of the peptide.
Fig. 2 The PSD mass spectrum of singly caesiated angiotensin II
[Ang+Cs]+ shows only minor fragmentation. Therefore, the inner region
(m/z from 200 to 1000) of the mass spectrum has been enlarged in the
PSD mass spectra (* denotes the singly caesiated yi fragment). The lower
part shows a possible molecular structure of [Ang+Cs]+. The Cs cation
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the peptide due to the loss of the acidic Asp residue. The
substantial ion signal of the b7-17 fragment is in agreement with
reaction schemes presented by Grese et al. and Teesch et al.
(and references therein).20,21 These studies suggest that the
cation attacks the C-terminus and the peptide loses a –CQO
and an amino group with the residue nearby. A protonation/
deprotonation of single amino-acid residues shows a rather low
inﬂuence on the secondary structure if caesium is attached.
The absence of protonated fragments also suggests a strong
bonding of the cation to the peptide and an inhibition of
charge transport inside the analyte molecule. A possible
reason could be the size/mass of the Cs cation.
3.3 Doubly caesiated angiotensin II
This molecule shows more fragmentation than [Ang+Cs]+, as
displayed in the PSD mass spectrum of [Ang+2Cs-H]+(see
Fig. 3). Here the m/z values of the y-fragments are shifted by
[2Cs-H] = 265 Da. Also in this case, mostly [yi+2Cs]
+-
fragments have been detected. Additionally, there are some
mass peaks which could not be assigned. The molecular
structure of [Ang+2Cs-H]+ is shown in Fig. 3. The structure
shows both Cs atoms/cations in a cage of the peptide. Some
MD simulations show a separation of the Cs atom(s)/cation(s)
by a cyclic amino acid residue. In almost all calculated
structures, the Cs atom(s)/cation(s) are surrounded by the
ring structures of the tyrosine, phenylalanine and histidine
side chains. MD simulations suggest that the protonation/
deprotonation of single amino acids is not crucial for the
secondary structure of Cs+-substituted angiotensin II. This
result can also be interpreted by the increased interaction of Cs
cations with the peptide compared to the interaction of the
peptides with an additional proton. The lack of singly caesiated
fragments in the mass spectra indicates the formation of the
[2Cs] cation inside the peptide cage. Also in the case of the
doubly caesiated angiotensin II, the molecular structure seems
to be stabilized by electrostatic interaction of the cations and
the (deprotonated) peptide.
3.4 Triply caesiated angiotensin II
InMALDI mass spectra, the peak intensity of [Ang+3Cs-2H]+
is rather low in comparison to the other analyte peak intensities.
One reason could be the high reaction barrier of the proton/
cation exchange reaction during the MALDI process. Also the
PSD mass spectra of [Ang+3Cs-2H]+ (shown in Fig. 4) exhibit
low signal intensities in comparison to the protonated or the
singly caesiated species. This low ion signal is in agreement with
former results.14 Since the ratio of the fragment peak intensities
and the [Ang+3Cs-2H]+ is rather high, this structure seems to
be less stable than the singly and doubly Cs+-substituted
angiotensin II. In the PSD mass spectrum there are several
fragments, which cannot be assigned to caesiated fragments. The
fragment peak intensities are in the same range as the analyte
Fig. 3 In the upper part of this ﬁgure, the PSD mass spectrum of
doubly caesiated angiotensin II is shown. There is onlyminor fragmentation
of [Ang+2Cs-H]+ in the gas phase.Most fragments are y fragments. yi**
stands for [yi+2Cs-H]. Every identiﬁed fragment is doubly caesiated. The
lower part of this ﬁgure shows a geometrically optimized structure of
[Ang+2Cs-H]+. Both Cs atoms are nearby and surrounded by (hetero)
cyclic residues.
Fig. 4 The PSD mass spectrum of [Ang+3Cs-2H] shows rather high
fragmentation in comparison to the other caesiated species, yet many
peaks could not be identiﬁed. Besides triply caesiated fragments (denoted
with ***) there is also one doubly caesiated fragment (denoted by **). The
lower part shows the geometrically optimized structure of [Ang+3Cs-2H].
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peak intensity. In contrast to the other PSD mass spectra, there
is a fragment which contains only two Cs atoms instead of three.
The calculated molecular structure is likely a [2Cs] dimer
structure and one separated Cs atom/cation as several MD
simulations suggest. This Cs dimer could explain the [y2+2Cs]
+
fragment. The molecular structure also suggests an interaction
between the Cs+ cation(s)/atom(s) and the cyclic structures of
tyrosine, phenylalanine, histidine, and the deprotonated terminus.
This seems to be the main factor for stabilization of the triply
caesiated angiotensin II. The molecular structure in this case
suggests a similar interaction between the cluster and the hetero-
cyclic (or polar) amino acid residues. Repulsive interaction
between the caesium cations could contribute to increased peptide
fragmentation of the mainly linear peptide backbone. This
repulsion can be seen as a reason for the higher fragmentation
rate of [Ang+3Cs-2H]+. Also the [y2+2Cs]
+ fragment
indicates the repulsive interaction of the Cs atom/cation and
the Cs dimer located close to each other.
4 Conclusion
The PSD mass spectra of caesiated angiotensin II have been
presented in combination with the calculated molecular structures.
PSD analysis of caesiated angiotensin II shows a very low
fragmentation rate of caesiated angiotensin II in comparison
to the protonated species. This suggests a higher gas phase
stability of caesiated angiotensin II than the protonated one.
In order to explain the experimental results, the molecular
structures have been calculated. An important feature is the
strong modiﬁcation of the secondary structure of cationized
angiotensin II in comparison to its protonated form. A more
compact structure with additional interactions could lead to
minor fragmentation of caesiated angiotensin II. Fragments of
[Ang+Cs]+ and [Ang+2Cs-H]+ only show (Cs or 2Cs-H,
respectively) shifted fragments. Most calculated structures
suggest that cations interact with the (delocalized) p-systems
of the cyclic amino acid residues––tyrosine, histidine or
phenylalanine. This interaction seems to be stronger than the
van-der-Waals interaction of the cation and the polar oxygen
atoms of the peptide backbone (oxyphilic interaction) since
only a few calculated structures stay in such a position. These
further interactions change the secondary structure of the
peptide considerably and increase the gas-phase stability of
the caesiated peptides in comparison to the protonated
angiotensin II. This is also in agreement with results of
Dougherty and co-workers, who examined in detail the inter-
action of charged particles and (hetero-) cyclic structures.34 For
higher caesiated species, especially in the case of [Ang+3Cs-2H]+,
the caesium cations/dimer could also interact repulsively. This
could explain the lower stability of the triply cationized peptide in
the gas phase as the higher fragmentation rate suggests, visible in
the PSD mass spectrum of [Ang+3Cs-2H]. The substitution with
other cations such as potassium or rubidium in angiotensin II
shows similar eﬀects (not shown here). These results transferred to
systems in solution could give a hint as to how cation concentra-
tions in blood could inﬂuence the eﬀectiveness of hormones in a
metabolic context. The ﬁnding that the interaction of the cyclic
structures and the cations is more important than the precise
positions of the protons at the peptide could show a way to
interpret the relevant factor of salt concentration in biological
(metabolic) systems.
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